673 — China Health Cashflow Statement
0.000.00%
- HK$319.57m
- HK$332.78m
- HK$38.94m
Annual cashflow statement for China Health, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -5.33 | -8.71 | -39.4 | -42.3 | -67.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -4.43 | -1.72 | 27.2 | 12.1 | 45.4 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.81 | 38.3 | -11.6 | 19.3 | 11.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9 | 31.9 | -19.6 | -6.4 | -6.76 |
Capital Expenditures | -1.84 | -0.795 | -1.37 | -0.624 | -1.59 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.008 | -34.5 | -3.53 | 0.323 | 0.009 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.83 | -35.3 | -4.9 | -0.301 | -1.58 |
Financing Cash Flow Items | -0.07 | -0.153 | -0.449 | -0.229 | -0.159 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.56 | 12.8 | 27.1 | -1.24 | 8.79 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5.65 | 3.94 | 2.94 | -7.47 | -2.96 |